Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

A raw and honest look at one woman's decades-long struggle with pain and undiagnosed fibromyalgia, and the breakthrough moment that changed everything ...

Though researchers still don’t know what causes the disorder, studies show that people with fibromyalgia have an increased ...

Core offers FDA-approved nVNS devices with growth potential in healthcare and military markets. Click here to find out what ...

The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

Tonix Pharmaceuticals Holding Corp. recently revealed in an 8-K filing with the U.S. Securities and Exchange Commission that the U.S. Food and Drug Administration (FDA) has set a Prescription Drug ...

The prevalence of fibromyalgia is higher among patients with SLE vs the general population, adding to an already significant ...

The following is a summary of “Fibromyalgia severity and symptoms are associated with the disorders of gut–brain interaction, ...

Tonix Pharmaceuticals (TNXP) announced that the U.S. Food and Drug Administration, FDA, assigned a Prescription Drug User Fee Act, PDUFA, goal ...

A new finding of post-exertional malaise in 20% of people with fibromyalgia might be an overestimate, but when ...

Nerve stimulation company electroCore has signed an agreement to acquire NeuroMetrix and its Quell wearable device aimed at fibromyalgia and chronic pain. | The deal, valued at about $9 million in ...

The following is a summary of “Pain sensitization in fibromyalgia. Cross-sectional associations between quantitative sensory ...